Publicaciones en las que colabora con Rodrigo Jover Martínez (21)

2024

  1. Use of multi-gene panels in patients at high risk of hereditary digestive cancer: position statement of AEG, SEOM, AEGH and IMPaCT-GENÓMICA consortium

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 3, pp. 293-318

2022

  1. Lynch-like Syndrome: Potential Mechanisms and Management

    Cancers, Vol. 14, Núm. 5

2021

  1. Clinical Frailty Score vs Hospital Frailty Risk Score for predicting mortality and other adverse outcome in hospitalised patients with COVID-19: Spanish case series

    International Journal of Clinical Practice, Vol. 75, Núm. 10

2020

  1. Clinical and Pathological Characterization of Lynch-Like Syndrome

    Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 2, pp. 368-374.e1

  2. Risk of cancer in family members of patients with lynch-like syndrome

    Cancers, Vol. 12, Núm. 8, pp. 1-12

2018

  1. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy

    PLoS ONE, Vol. 13, Núm. 9

2017

  1. Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives

    Gastroenterology, Vol. 153, Núm. 1, pp. 106-112.e2

  2. KRAS and BRAF somatic mutations in colonic polyps and the risk of metachronous neoplasia

    PLoS ONE, Vol. 12, Núm. 9

2015

  1. Prevalence of MLH1 constitutional epimutations as a cause of Lynch syndrome in unselected versus selected consecutive series of patients with colorectal cancer

    Journal of Medical Genetics, Vol. 52, Núm. 7, pp. 498-502

2014

  1. New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis

    Human Molecular Genetics, Vol. 23, Núm. 13, pp. 3506-3512

  2. Prevalence and characteristics of mutyh-associated polyposis in patients with multiple adenomatous and serrated polyps

    Clinical Cancer Research, Vol. 20, Núm. 5, pp. 1158-1168

2013

  1. Clinical subtypes and molecular characteristics of serrated polyposis syndrome

    Clinical Gastroenterology and Hepatology, Vol. 11, Núm. 6, pp. 705-711

  2. Risk of cancer in cases of suspected lynch syndrome without germline mutation

    Gastroenterology, Vol. 144, Núm. 5

2012

  1. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer

    Gut, Vol. 61, Núm. 6, pp. 865-872

  2. Recurrent testicular germ cell tumors in a family with MYH-Associated polyposis

    Journal of Clinical Oncology, Vol. 30, Núm. 23

2011

  1. Clinically important molecular features of Peruvian colorectal tumours: High prevalence of DNA mismatch repair deficiency and low incidence of KRAS mutations

    Pathology, Vol. 43, Núm. 3, pp. 228-233

  2. Evidence for classification of c.1852_1853AA>GC in MLH1 as a neutral variant for Lynch syndrome

    BMC Medical Genetics, Vol. 12

2010

  1. EPCAM germ line deletions as causes of lynch syndrome in Spanish patients

    Journal of Molecular Diagnostics, Vol. 12, Núm. 6, pp. 765-770

  2. Impact of TACSTD1 germline deletions as Lynch syndrome causing mutations in Spanish hereditary non-polyposis colorectal cancer - suspected patients

    EJC SUPPLEMENTS

  3. Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome

    Journal of Molecular Diagnostics, Vol. 12, Núm. 4, pp. 498-504